1Gurcharn Singh,Marian K. Luna,Bach Ardalan. Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell lines[J] 1988,Cancer Chemotherapy and Pharmacology(3):191～196
2Bharathi Vayuvegula,Lewis Slater,Josephine Meador,Sudhir Gupta. Correction of altered plasma membrane potentials[J] 1988,Cancer Chemotherapy and Pharmacology(2):163～168
3Ratna Bose,Hing-Yat Peter Lam. Membrane transport changes in an adriamycin-resistant murine leukemia cell line and in its sensitive parental cell line[J] 1988,Cancer Chemotherapy and Pharmacology(1):14～18
4Takashi Tsuruo,Takeshi Matsuzaki,Miyuki Matsushita,Harumi Saito,Teruo Yokokura. Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo[J] 1988,Cancer Chemotherapy and Pharmacology(1):71～74
5S. Radel,I. Bankusli,E. Mayhew,Y. M. Rustum. The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and-sensitive leukemia in vitro and in vivo[J] 1988,Cancer Chemotherapy and Pharmacology(1):25～30
6Geetha Vasanthakumar,Nahed K. Ahmed. Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells[J] 1986,Cancer Chemotherapy and Pharmacology(2):105～110
